BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 9687024)

  • 1. Arginine (348) is a major determinant of the DNA binding specificity of transcription factor E12.
    Sieber M; Allemann RK
    Biol Chem; 1998 Jun; 379(6):731-5. PubMed ID: 9687024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquisition of myogenic specificity through replacement of one amino acid of MASH-1 and introduction of an additional alpha-helical turn.
    Dezan C; Meierhans D; Künne AG; Allemann RK
    Biol Chem; 1999 Jun; 380(6):705-10. PubMed ID: 10430036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of DNA sequence in the binding specificity of synthetic basic-helix-loop-helix domains.
    Beltran AC; Dawson PE; Gottesfeld JM
    Chembiochem; 2005 Jan; 6(1):104-13. PubMed ID: 15593070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covalently linking BHLH subunits of MASH-1 increases specificity of DNA binding.
    Künne AG; Allemann RK
    Biochemistry; 1997 Feb; 36(5):1085-91. PubMed ID: 9033398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of the myogenic determination factor myogenin with E12 and a DNA target: mechanism and kinetics.
    Spinner DS; Liu S; Wang SW; Schmidt J
    J Mol Biol; 2002 Mar; 317(3):431-45. PubMed ID: 11922675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MyoD-E12 heterodimers and MyoD-MyoD homodimers are equally stable.
    Maleki SJ; Royer CA; Hurlburt BK
    Biochemistry; 1997 Jun; 36(22):6762-7. PubMed ID: 9184158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decoding hematopoietic specificity in the helix-loop-helix domain of the transcription factor SCL/Tal-1.
    Schlaeger TM; Schuh A; Flitter S; Fisher A; Mikkola H; Orkin SH; Vyas P; Porcher C
    Mol Cell Biol; 2004 Sep; 24(17):7491-502. PubMed ID: 15314159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermodynamics of the DNA binding reaction of transcription factor MASH-1.
    K-unne AG; Sieber M; Meierhans D; Allemann RK
    Biochemistry; 1998 Mar; 37(12):4217-23. PubMed ID: 9521744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NMR solution structure of a mutant of the Max b/HLH/LZ free of DNA: insights into the specific and reversible DNA binding mechanism of dimeric transcription factors.
    Sauvé S; Tremblay L; Lavigne P
    J Mol Biol; 2004 Sep; 342(3):813-32. PubMed ID: 15342239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12.
    Ryan DP; Duncan JL; Lee C; Kuchel PW; Matthews JM
    Proteins; 2008 Mar; 70(4):1461-74. PubMed ID: 17910069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlling the DNA binding specificity of bHLH proteins through intramolecular interactions.
    Turner EC; Cureton CH; Weston CJ; Smart OS; Allemann RK
    Chem Biol; 2004 Jan; 11(1):69-77. PubMed ID: 15112996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A BMAL1 mutant with arginine 91 substituted with alanine acts as a dominant negative inhibitor.
    Hosoda H; Motohashi J; Kato H; Masushige S; Kida S
    Gene; 2004 Sep; 338(2):235-41. PubMed ID: 15315827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA binding specificity of the basic-helix-loop-helix protein MASH-1.
    Meierhan D; el-Ariss C; Neuenschwander M; Sieber M; Stackhouse JF; Allemann RK
    Biochemistry; 1995 Sep; 34(35):11026-36. PubMed ID: 7669760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human homologue of maid: A dominant inhibitory helix-loop-helix protein associated with liver-specific gene expression.
    Terai S; Aoki H; Ashida K; Thorgeirsson SS
    Hepatology; 2000 Aug; 32(2):357-66. PubMed ID: 10915743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The basic helix-loop-helix domain of the E47 transcription factor requires other protein regions for full DNA binding activity.
    Lu J; Sloan SR
    Biochem Biophys Res Commun; 2002 Feb; 290(5):1521-8. PubMed ID: 11820794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative regulation of selected bHLH proteins by eHAND.
    Bounpheng MA; Morrish TA; Dodds SG; Christy BA
    Exp Cell Res; 2000 Jun; 257(2):320-31. PubMed ID: 10837146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antimyogenin antibodies define epitopes outside the bHLH domain where binding interferes with protein-protein and protein-DNA interactions.
    Wright WE; Dac-Korytko I; Farmer K
    Dev Genet; 1996; 19(2):131-8. PubMed ID: 8900045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition properties of a sequence-specific DNA binding antibody.
    LeBlanc JF; McLane KE; Parren PW; Burton DR; Ghazal P
    Biochemistry; 1998 Apr; 37(17):6015-22. PubMed ID: 9558339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperative activation of atrial naturetic peptide promoter by dHAND and MEF2C.
    Zang MX; Li Y; Xue LX; Jia HT; Jing H
    J Cell Biochem; 2004 Dec; 93(6):1255-66. PubMed ID: 15486975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for the diversity of DNA recognition by bZIP transcription factors.
    Fujii Y; Shimizu T; Toda T; Yanagida M; Hakoshima T
    Nat Struct Biol; 2000 Oct; 7(10):889-93. PubMed ID: 11017199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.